These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1502753)
1. Use of gadolinium-DTPA-enhanced MRI to characterize renal mass in patient with renal insufficiency. Terens WL; Gluck R; Golimbu M; Rofsky NM Urology; 1992 Aug; 40(2):152-4. PubMed ID: 1502753 [TBL] [Abstract][Full Text] [Related]
2. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Rofsky NM; Weinreb JC; Bosniak MA; Libes RB; Birnbaum BA Radiology; 1991 Jul; 180(1):85-9. PubMed ID: 2052729 [TBL] [Abstract][Full Text] [Related]
3. Dynamic MRI of small renal cell carcinoma. Yamashita Y; Miyazaki T; Hatanaka Y; Takahashi M J Comput Assist Tomogr; 1995; 19(5):759-65. PubMed ID: 7560322 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging of the kidney: comparison of T1-weighted and T2*-weighted sequences. Tsushima Y; Niemi P; Komu M; Dean PB; Haapanen A; Kormano M Acad Radiol; 1996 Aug; 3 Suppl 2():S176-8. PubMed ID: 8796555 [No Abstract] [Full Text] [Related]
12. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT. Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260 [TBL] [Abstract][Full Text] [Related]
13. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T Magn Reson Imaging; 1994; 12(3):421-7. PubMed ID: 8007771 [TBL] [Abstract][Full Text] [Related]
14. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images. Yancey JM; Ackerman N; Kaude JV; Googe RE; Fitzsimmons JR; Scott KN; Mancuso AA; Hackett RL; Hager DA; Caballero S Acta Radiol; 1987; 28(4):479-82. PubMed ID: 2958067 [TBL] [Abstract][Full Text] [Related]
15. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance]. Torricelli P; Montanari N; De Santis M; Pollastri C Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging enhanced with a macromolecular contrast agent. Detection of the zonal renal ischemia. Vexler VS; Berthezene Y; Moseley ME; Brasch RC Invest Radiol; 1991 Nov; 26 Suppl 1():S131-3; discussion S137-8. PubMed ID: 1808109 [No Abstract] [Full Text] [Related]
17. Contrast-enhanced MR imaging of the kidneys and adrenal glands. Huch Böni RA; Debatin JF; Krestin GP Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):101-31. PubMed ID: 8673709 [TBL] [Abstract][Full Text] [Related]
18. Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Eilenberg SS; Lee JK; Brown J; Mirowitz SA; Tartar VM Radiology; 1990 Aug; 176(2):333-8. PubMed ID: 2367649 [TBL] [Abstract][Full Text] [Related]
19. Detection of renal ischemic lesions using Gd-DTPA enhanced turbo FLASH MRI: experimental and clinical results. Vosshenrich R; Kallerhoff M; Gröne HJ; Fischer U; Funke M; Kopka L; Siebert G; Ringert RH; Grabbe E J Comput Assist Tomogr; 1996; 20(2):236-43. PubMed ID: 8606230 [TBL] [Abstract][Full Text] [Related]
20. [Clinical value of new rapid nuclear magnetic resonance tomography in preoperative assessment of hypernephroma. A prospective comparative study of CT and MR]. Vorreuther R; Krestin GP; Franzen W; Engelking R; Friedmann G Urologe A; 1990 Jan; 29(1):39-42. PubMed ID: 2316079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]